Fence Spikes Uk

Acid Extractable Matrix Spikes
CLPS-MSA15-TI 1ML
EUR 52.8

Human IgG antibody Laboratories manufactures the fence spikes uk reagents distributed by Genprice. The Fence Spikes Uk reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S. Other Fence products are available in stock. Specificity: Fence Category: Spikes Group: Uk

UK 1
5 mg
EUR 1657.2
Description: UK 1, an unusual bis-benzoxazole metabolite isolated from Streptomyces sp. 517-02, is an inhibitor of topoisomerase II (Topo II) and hepatitis C viral replication.

UK-5099
10 mg
EUR 208.8
Description: UK-5099 is a potent inhibitor of the mitochondrial pyruvate carrier [1]. The mitochondrial pyruvate carrier (MPC) facilitates pyruvate transport across the mitochondrial inner membrane and plays a critical role in carbohydrate, lipid and amino acid metabolism.

UK-5099
50 mg
EUR 661.2
Description: UK-5099 is a potent inhibitor of the mitochondrial pyruvate carrier [1]. The mitochondrial pyruvate carrier (MPC) facilitates pyruvate transport across the mitochondrial inner membrane and plays a critical role in carbohydrate, lipid and amino acid metabolism.

UK 383367
10 mg
EUR 176.4
Description: UK 383367 is a novel procollagen C-protein (PCP) inhibitor being investigated for the treatment of post-surgical dermal scarring, which potently inhibits the activity of PCP with the value of 50% inhibition concentration IC50 of 44 nM.

UK 383367
25 mg
EUR 292.8
Description: UK 383367 is a novel procollagen C-protein (PCP) inhibitor being investigated for the treatment of post-surgical dermal scarring, which potently inhibits the activity of PCP with the value of 50% inhibition concentration IC50 of 44 nM.

UK 383367
5 mg
EUR 142.8
Description: UK 383367 is a novel procollagen C-protein (PCP) inhibitor being investigated for the treatment of post-surgical dermal scarring, which potently inhibits the activity of PCP with the value of 50% inhibition concentration IC50 of 44 nM.

UK 356618
10 mg
EUR 633.6
Description: Potent and selective inhibitor of MMP-3 (IC50 = 5.9 nM). Displays selectivity over a range of MMPs (IC50 values are 73, 840, 1790, 1900 and 51000 for MMP-13, MMP-9, MMP-2, MMP-14 and MMP-1 respectively).

Uk information

SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag
E80022
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml

Spike S1 (B.1.351), Avi-His-Tag (SARS-CoV-2)
100992-1 100 µg
EUR 320
Description: Recombinant SARS-CoV-2 Spike protein, S1 subunit encompassing amino acids 16-685. This protein corresponds to SARS-CoV-2 Variant B.1.351 originally identified in South Africa and contains mutations L18F, D80A, D215G, R246I, K417N, E484K, N501Y, D614G. It also contains a C-terminal Avi-Tag™ followed by a C-terminal His-tag (6xHis). The recombinant protein is ≥90% pure following affinity purification. 

Spike S1 (B.1.351), Avi-His-Tag (SARS-CoV-2)
100992-2 1 mg
EUR 2850
Description: Recombinant SARS-CoV-2 Spike protein, S1 subunit encompassing amino acids 16-685. This protein corresponds to SARS-CoV-2 Variant B.1.351 originally identified in South Africa and contains mutations L18F, D80A, D215G, R246I, K417N, E484K, N501Y, D614G. It also contains a C-terminal Avi-Tag™ followed by a C-terminal His-tag (6xHis). The recombinant protein is ≥90% pure following affinity purification. 

UK-5099
B1952-25 each
EUR 652.8

UK-5099
B1952-5 each
EUR 210

UK 14,304
B3465-10 10 mg
EUR 228

UK 14,304
B3465-100 100 mg
EUR 1232.4

UK 14,304
B3465-5 5 mg
EUR 166.8

UK 14,304
B3465-50 50 mg
EUR 714

UK 1
C5006-1 1 mg
EUR 435.6
Description: UK 1, an unusual bis-benzoxazole metabolite isolated from Streptomyces sp. 517-02, is an inhibitor of topoisomerase II (Topo II) and hepatitis C viral replication.

UK 1
C5006-5 5 mg
EUR 1657.2
Description: UK 1, an unusual bis-benzoxazole metabolite isolated from Streptomyces sp. 517-02, is an inhibitor of topoisomerase II (Topo II) and hepatitis C viral replication.

UK-5099
A3899-10 10 mg
EUR 208.8
Description: UK-5099 is a potent inhibitor of the mitochondrial pyruvate carrier [1]. The mitochondrial pyruvate carrier (MPC) facilitates pyruvate transport across the mitochondrial inner membrane and plays a critical role in carbohydrate, lipid and amino acid metabolism.

UK-5099
A3899-50 50 mg
EUR 661.2
Description: UK-5099 is a potent inhibitor of the mitochondrial pyruvate carrier [1]. The mitochondrial pyruvate carrier (MPC) facilitates pyruvate transport across the mitochondrial inner membrane and plays a critical role in carbohydrate, lipid and amino acid metabolism.

UK 383367
A4354-10 10 mg
EUR 176.4
Description: UK 383367 is a novel procollagen C-protein (PCP) inhibitor being investigated for the treatment of post-surgical dermal scarring, which potently inhibits the activity of PCP with the value of 50% inhibition concentration IC50 of 44 nM.

UK 383367
A4354-25 25 mg
EUR 292.8
Description: UK 383367 is a novel procollagen C-protein (PCP) inhibitor being investigated for the treatment of post-surgical dermal scarring, which potently inhibits the activity of PCP with the value of 50% inhibition concentration IC50 of 44 nM.

UK 383367
A4354-5 5 mg
EUR 142.8
Description: UK 383367 is a novel procollagen C-protein (PCP) inhibitor being investigated for the treatment of post-surgical dermal scarring, which potently inhibits the activity of PCP with the value of 50% inhibition concentration IC50 of 44 nM.

UK 356618
A4440-10 10 mg
EUR 633.6
Description: Potent and selective inhibitor of MMP-3 (IC50 = 5.9 nM). Displays selectivity over a range of MMPs (IC50 values are 73, 840, 1790, 1900 and 51000 for MMP-13, MMP-9, MMP-2, MMP-14 and MMP-1 respectively).